MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, K.
Right arrow Articles by Igarashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, K.
Right arrow Articles by Igarashi, K.

Vol. 53, Issue 5, 933-941, May 1998

The Selectivity Filter of the N-Methyl-D-Aspartate Receptor: A Tryptophan Residue Controls Block and Permeation of Mg2+

Keith Williams, Albert J. Pahk, Keiko Kashiwagi, Takashi Masuko, Nguyen D. Nguyen, and Kazuei Igarashi

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania (K.W., A.J.P., N.D.N.), and Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.K., T.M., K.I.)

    Summary
Top
Summary
Introduction
Materials & Methods
Results & Discussion
References

A hallmark feature of N-methyl-D-aspartate (NMDA) receptors is their voltage-dependent block by extracellular Mg2+. The structural basis for Mg2+ block is not fully understood. Although asparagine residues in the pore-forming M2 regions of NR1 and NR2 subunits influence Mg2+ block, it has been speculated that additional residues are likely to be involved. Here, we report the unexpected finding that a tryptophan residue in the M2 region of NR2 subunits controls Mg2+ block. An NR2B(W607L) mutation abolished block and greatly increased permeation of extracellular Mg2+. A similar effect was seen with a mutation at the equivalent residue in NR2A but not with mutations at the equivalent residue or adjacent residues in NR1. In NR2B, mutations that changed NR2B(W607) to asparagine (W607N) or alanine (W607A) also greatly reduced Mg2+ block, whereas mutations that changed W607 to the aromatic residues tyrosine (W607Y) or phenylalanine (W607F) had little or no effect on Mg2+ block. Furthermore, the W607L, W607N, and W607A mutants, but not the W607Y and W607F mutants, decreased Ba2+ permeability of NMDA channels. Thus, residue NR2B(W607) may be involved in binding of divalent cations, in particular Mg2+, through a cation-pi interaction with the electron-rich aromatic ring of the tryptophan. We previously suggested that NR2B(W607) may contribute to the narrow constriction of the NMDA channel. A model is now proposed in which the M2 loop of NR2B is folded in such a way that NR2B(W607) is positioned at the narrow constriction, at a level similar to NR2B(N616) and NR1(N616), with these three residues forming a binding site for Mg2+.

    Introduction
Top
Summary
Introduction
Materials & Methods
Results & Discussion
References

NMDA receptors are glutamate-gated ion channels that are involved in synaptic plasticity and ischemic neuronal cell death. A hallmark feature of NMDA receptors is their voltage-dependent block by extracellular Mg2+ (Mayer et al., 1984; Nowak et al., 1984). NMDA channels are blocked by Mg2+ at resting membrane potentials, and the block is relieved as neurons are depolarized, which allows the receptors to function as synaptic coincidence detectors.

NMDA receptors are hetero-oligomers containing combinations of NR1 and NR2 subunits in as-yet-undefined ratios and stoichiometries (Luo et al., 1997; Monyer et al., 1992; Moriyoshi et al., 1991; Sheng et al., 1994). The receptor subunits are thought to contain three membrane-spanning regions (M1, M3, and M4) and a reentrant loop (M2) that contributes to the permeation pathway of the ion channel (Bennett and Dingledine, 1995; Wo and Oswald, 1995; Wood et al., 1995). Asparagine residues in the M2 segments of NR1 and NR2 subunits influence block by Mg2+ and permeation of Ca2+ or Ba2+ (Burnashev et al., 1992; Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993; Kupper et al., 1996). These residues, which include N616 in NR1, N615 in NR2A, and N616 in NR2B, seem to contribute to the narrowest constriction of the channel pore (Kuner et al., 1996; Wollmuth et al., 1996) and may form part of a binding site for Mg2+. It is conceivable that other residues in the channel pore may be involved in block by Mg2+, but such residues have not yet been identified. Many studies of NMDA channel function have focused initially on amino acid residues in the NR1 subunit, followed by studies of the equivalent or adjacent residues in NR2 subunits. This strategy identified an important role of the asparagines at NR1(N616) and NR2B(N616) in Mg2+ block, but other residues that have been studied in the M2 region of NR1 have no effect or only modest effects on Mg2+ block (Burnashev et al., 1992; Mori et al., 1992; Kawajiri and Dingledine, 1993; Sakurada et al., 1993; Kupper et al., 1996). We recently found that tryptophan residues in the M2 regions of NR2 subunits, including W607 in NR2B, influence permeation of the novel polyamine channel blocker N1-DnsSpm (Kashiwagi et al., 1997). Here, we show that mutations at NR2B(W607), but not at the equivalent position in the NR1 subunit, greatly influence block by extracellular Mg2+. This tryptophan residue may form part of the selectivity filter and the Mg2+ binding site of the NMDA channel, and the results of this study have implications for understanding the structure of the M2 loop and the roles of different NMDA receptor subunits in channel function.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 1.   Mutations at NR2B(W607L) alter block of NMDA receptors by Mg2+. A, Schematic showing the putative topology of NMDA receptor subunits, with three membrane-spanning domains (M1, M3, M4) and a reentrant loop (M2). The amino acid sequences (single letter code) in the M2 regions of NR1, NR2A, and NR2B are shown; amino acids are numbered from the initiator methionine in each subunit. B, Effects of 100 µM Mg2+ on inward currents induced by glutamate (glu, 10 µM; with 10 µM glycine) were measured in oocytes expressing wild-type and mutant receptors and voltage-clamped at -70 mV. C, Concentration-inhibition curves were measured at NR1/NR2B (open circle ), NR1(W608L)/NR2B (black-triangle), and NR1/NR2B(W607L) (black-square) at -70 mV (mean ± standard error from three or four oocytes for each subunit combination). D-F, I-V curves were constructed by using voltage ramps (inset in D) in oocytes activated by glutamate and glycine (10 µM each) in the absence and presence of Mg2+ (1-1000 µM) in cells expressing NR1/NR2B (D), NR1/NR2B(W607L) (E), and NR1/NR2B(W607Y) receptors. Leak currents, measured by ramps applied in the absence of glutamate, glycine, and Mg2+, have been subtracted. G, Currents measured in the presence of 10 µM Mg2+ at NR1/NR2B and NR1/NR2B(W607Y) receptors were normalized to the current measured at +40 mV in each oocyte and the traces superimposed.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Block of mutant NMDA receptors by Mg2+

IC50 values for Mg2+ were determined from concentration-response curves, similar to those shown in Fig. 1C, in oocytes voltage-clamped at -70 mV and activated by 10 µM glutamate plus 10 µM glycine. Values are the geometric mean (- standard error, + standard error).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Sensitivity of NR2B(W607) mutants to pH, glutamate, and glycine

IC50 values (mean ± standard error) for pH inhibition were determined by measuring responses to glutamate over a pH range of 6.5 to 8.5 as described previously (Kashiwagi et al., 1997). EC50 values for glutamate and glycine were determined from concentration-response curves for each agonist in the presence of 10 µM glycine (glutamate curves) or 10 µM glutamate (glycine curves). Values are the geometric mean (- standard error, + standard error).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 2.   Mg2+ permeates NR1/NR2B(W607L) channels. A, Responses to glutamate and glycine (10 µM each; glu) were measured in oocytes voltage-clamped at -70 mV in an extracellular solution containing 96 mM Na+, 2 mM K+, and 1.8 mM Ba2+ (Na+ saline) or a solution containing 64 mM Mg2+ as the only cation (Mg2+ saline). B, I-V curves were constructed by using voltage ramps (-100 mV to +60 mV over 4 sec) in oocytes activated by glutamate and glycine (10 µM each) in Na+ saline or Mg2+ saline. Leak currents have been subtracted. Inset for NR1/NR2B(W607Y) shows an expanded view (-40 to +40 nA) of the I-V curves over the range of -100 to 0 mV to illustrate the very small inward current carried by Mg2+ in this cell. C, Reversal potentials (Vrev) at wild-type and mutant receptors were determined in Na+ saline (open circle ) and Mg2+ saline (bullet ) by using voltage ramps. At NR1/NR2B receptors, inward currents could not be detected in Mg2+ saline and a symbol with an arrow is drawn below -100 mV to indicate that Mg2+ is presumed to be impermeable or to have a Vrev more negative than -100 mV. D, The ratio of the slope conductance measured at -50 mV and +50 mV (G-50/G+50) in Mg2+ saline is shown for each mutant. E, Values for Vrev were determined in Na+ saline (open circle ) and Ba2+ saline (black-triangle) by using voltage ramps. Numbers in parentheses at the extreme right of each panel, the mean shift in Vrev in Ba2+ compared with Na+ for each receptor type. Values are mean ± standard error from 5-16 oocytes for each subunit combination. Values of Vrev have been corrected for small liquid junction potentials observed in Mg2+ saline and Ba2+ saline. Where errors are not shown, they are within the size of the symbol.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Mg2+ permeation at mutant NMDA receptors. I-V curves were constructed by using voltage ramps (-100 mV to +60 mV over 4 sec) in oocytes activated by glutamate and glycine (10 µM each) in Na+ saline or Mg2+ saline. Leak currents have been subtracted. B and C, insets, expanded view (-10 to +30 nA or -10 to +10 nA) of the I-V curves over the range of -100 mV to 0 mV to illustrate the very small inward currents carried by Mg2+ in these cells.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4.   Properties of mutant NMDA receptors. Left, reversal potentials (Vrev) at wild-type and mutant receptors were determined in Na+ saline (open circle ) and Mg2+ saline (bullet ) by using voltage ramps. In oocytes in which inward currents could not be detected in Mg2+ saline (e.g., NR1/NR2B), Vrev for Mg2+ is not known, and the symbol with an arrow, below -100 mV, is drawn to indicate that Mg2+ is presumed to be impermeable or to have a Vrev more negative than -100 mV. Right, values for Vrev were determined in Na+ saline (open circle ) and Ba2+ saline (black-triangle) by using voltage ramps. Numbers in parentheses, mean shift in Vrev in Ba2+ compared with Na+ for each receptor type. Data are presented in four groups (A-D) to facilitate comparison between various mutants or combinations of mutants, and some data, for example, NR1/NR2B(W607L), are presented in two or more groups to facilitate comparison with related mutants or groups of mutants. A-C, Data from receptors containing NR2B. D, Data from receptors containing NR2A. Values, which are mean ± standard error from 4-16 oocytes for each subunit combination, have been corrected for small liquid junction potentials observed in Mg2+ saline and Ba2+ saline. Where errors are not shown, they are within the size of the symbol. ND, not determined; macroscopic currents through NR1(N616W)/NR2B(W607L) channels were only 1-7 nA in Na+ saline.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   Models of M2 loop structures and Mg2+ block. A, The M2 loop regions of NR1 and NR2B are shown (shaded ribbons) with the positions of some N and W residues (circles). The structure of the M2 loop in NR1 is based on that proposed by Kuner et al. (1996), with N616 being at the tip of the loop and forming part of the narrow constriction of the channel, and W608 lying some distance below N616 but still being in the lumen of the channel. The structure of the M2 loop in NR2 subunits was previously suggested to be similar to that of NR1, with the second asparagine (N616 in NR2B) forming the narrowest part of the channel (Kuner et al., 1996). However, we proposed that residue W607 in NR2B also contributes to the narrow constriction of the channel (Kashiwagi et al., 1997) and forms part of the selectivity filter and Mg2+ binding site. To account for the effects seen with mutations at NR2B(W607), the M2 loop of NR2B is proposed to be folded in such a way that NR2B(W607) lies at a level in the channel similar to NR2B(N616) and NR1(N616). It is also possible that a similar structure exists for the M2 loop of NR1 (not illustrated), although mutations at NR1(W608) do not produce phenotypes like those seen with mutations at NR2B(W607). B, In NR1/NR2B receptors, the Mg2+ binding site of the NMDA channel is proposed to be formed by the asparagines at NR1(N616) and NR2B(N616) and the tryptophan at NR2B(W607) (bold letters in large circles). Block by Mg2+ could involve interactions with the carbonyl oxygens of the asparagine residues and a cation-pi interaction with the electron-dense aromatic ring of the tryptophan. An aromatic ring at position NR2B(607) also influences permeation of Ba2+, and it is conceivable that tryptophan 607 is important for transient binding and subsequent passage of Ba2+ through the channel (not illustrated). Mutations at NR2B(N615) and at NR2B(W610) also have small effects on Mg2+ block, and these residues may make weak contributions to the Mg2+ binding site (small circles). Residue NR1(W608), which is solvent accessible in the channel (Kuner et al., 1996), does not influence Mg2+ block and may lie some distance below NR1(N616), as shown here (also see Kuner et al., 1996) if the M2 loop structure is as shown in A.

    Materials and Methods
Top
Summary
Introduction
Materials & Methods
Results & Discussion
References

cDNA clones and site-directed mutagenesis. The wild-type NR1 clone (Moriyoshi et al., 1991) and the NR1(W608L) and NR1(F609L) mutants (Sakurada et al., 1993) were gifts from Dr. S. Nakanishi (Institute for Immunology, Kyoto University Faculty of Medicine, Kyoto, Japan). The NR1(N616R) mutant (Kawajiri and Dingledine, 1993) was a gift from Dr. R. J. Dingledine (Department of Pharmacology, Emory University, Atlanta, GA). The wild-type NR2A and NR2B clones (Monyer et al., 1992) were gifts from Dr. P. H. Seeburg (Center for Molecular Biology, University of Heidelberg, Germany). NR1 and NR2 mutants were prepared by site-directed mutagenesis using the M13 phage system (Kunkel et al., 1987; Sayers et al., 1992), and mutations were confirmed by DNA sequencing. In some experiments, we used a rat brain NR2B clone containing the W607L mutation (Kashiwagi et al., 1997). In other experiments, we used a mouse brain NR2B clone, epsilon 2 (Kutsuwada et al., 1992) (a gift from Dr. M. Mishina, University of Tokyo, Tokyo, Japan), containing a 1.7-kb HindIII/SphI fragment of the rat NR2B clone with the W607L mutation. A similar construct was used to prepare the NR2B(W607N), NR2B(W607A), NR2B(W607Y), and NR2B(W607F) mutants. In control experiments, we found that an epsilon 2 clone containing the wild-type HindIII/SphI fragment of rat NR2B had properties indistinguishable from wild-type NR2B (data not shown). Oligonucleotides (sense strands) used for preparation of NR2B mutants were 5'-CTG GTG TTT AAC GGC TCC GTA CCT GT-3' for NR2B(N616G), 5'-GGC AAA GCA ATT AAT TTA CTC TGG GGT C-3' for NR2B(W607N), 5'-GGC AAA GCA ATT GCC TTA CTC TGG GGT-3' for NR2B(W607A), 5'-GCA AAG CAA TTT ACT TAC TCT GGG GT-3' for NR2B(W607Y), and 5'-GCA AAG CAA TTT TCT TAC TCT GGG GT-3' for NR2B(W607F). The oligonucleotide for NR1(N616W) (antisense) was 5'-CCC CAA TGC CGG ACC AGA GCA GGA CGC CC-3'. Underlined nucleotides indicate the position of the mutations. The double mutant, NR2B(W607L,N616G) was prepared by using the oligonucleotide for the NR2B(N616G) mutation with a single-strand DNA fragment of NR2B that contained the W607L mutation. Other NR1 and NR2 mutants were prepared as described previously (Chao et al., 1997; Kashiwagi et al., 1997). Most of the 5'-UTR was removed from the NR2B (Williams, 1993) and epsilon 2 clones to improve expression in oocytes. The 5'-UTR of the epsilon 2 clone was truncated at the SalI site, leaving a 5'-UTR of 50 nucleotides.

Expression in oocytes and voltage-clamp recording. Defolliculated oocytes were prepared and maintained as described previously (Williams et al., 1993). Oocytes were injected with NR1 plus NR2 cRNAs in a ratio of 1:5 (0.2-4 ng of NR1 plus 1-20 ng of NR2). Macroscopic currents were recorded with a two-electrode voltage-clamp using a GeneClamp 500 amplifier (Axon Instruments, Foster City, CA) or an OC-725 amplifier (Warner Instruments, Hamden, CT) as described previously (Williams, 1993, 1994; Williams et al., 1993). Oocytes were continuously superfused with a saline solution (96 mM NaCl, 2 mM KCl, 1.8 mM BaCl2, 10 mM HEPES, pH 7.5) (Na+ saline). In most experiments, oocytes were injected with K+-BAPTA (100 nl of 40 mM, pH 7.0-7.4) on the day of recording (Williams, 1993).

Reversal potentials were calculated by linear regression of data over a 10-mV range, 5 mV positive and 5 mV negative to an estimated reversal potential. The slope conductances at -50 mV and at +50 mV were measured by linear regression of data from -45 to -55 mV and from +45 to +55 mV. In experiments using Mg2+ as the extracellular charge carrier, the Na+ saline was replaced with a solution that contained 64 mM MgC12, 2 mM KCl, and 10 mM HEPES, pH 7.5 (Mg2+ saline). In most experiments, the pH of this solution was adjusted to pH 7.5 using NaOH, and the Mg2+ saline therefore contained ~6 mM Na+. In some experiments, the pH of the solution was adjusted using Mg(OH)2, and the solution did not contain KCl; thus Mg2+ was the only extracellular cation in those experiments. No differences were observed between the reversal potentials measured in Mg2+ saline in which pH was adjusted with NaOH or with Mg(OH)2. In experiments using Ba2+ as the extracellular charge carrier, the Na+ saline was replaced with a solution that contained 64 mM BaC12, 2 mM KCl, and 10 mM HEPES, pH 7.5 (Ba2+ saline). There were small liquid junction potentials (+3 to +8 mV) when changing from Na+ saline to Mg2+ or Ba2+ saline. The reported values of Vrev have been corrected for these junction potentials.

    Results and Discussion
Top
Summary
Introduction
Materials & Methods
Results & Discussion
References

NR2B(W607) controls Mg2+ block. We initially studied W-to-L mutations at several positions in the M2 loop of the NR1 and NR2B subunits (Fig. 1A). Wild-type NR1/NR2B receptors were inhibited by Mg2+ with an IC50 value of 19 µM at -70 mV (Fig. 1, B and C; Table 1). Mutations in the NR1 subunit at W608L, W611L, or an adjacent aromatic residue, F609L, had no effect on Mg2+ block. In contrast, mutation NR2B(W607L) almost abolished block by extracellular Mg2+, which had little or no effect at concentrations up to 300 µM (Fig. 1C; Table 1). At higher concentrations (1-3 mM), Mg2+ potentiated glutamate-induced currents at NR1/NR2B(W607L) receptors, presumably due to an effect of Mg2+ at the stimulatory polyamine site (Paoletti et al., 1995). Stimulation by 1-3 mM Mg2+ was also seen at wild-type NR1/NR2B receptors at depolarized potentials (+40 to +60 mV) (data not shown). This form of Mg2+ stimulation, like that of spermine, seems to be voltage-independent and is presumably unmasked at negative membrane potentials at NR1/NR2B(W607L) receptors because of the lack of Mg2+ block at these receptors. A W-to-L mutation at residue NR2B(W610L), three residues downstream of W607 (Fig. 1A), also had a small effect on Mg2+ block, increasing the IC50 by ~3-fold (Table 1). Block by Mg2+ was also reduced in receptors containing a W-to-L mutation in the NR2A subunit at position NR2A(W606), although the effect of this mutation on the IC50 for Mg2+ was smaller than that of the equivalent mutation (W607L) in NR2B (Table 1).

We studied four other mutations, W-to-N, W-to-A, W-to-Y, and W-to-F, at NR2B(W607). The W-to-N and W-to-A mutants drastically reduced Mg2+ block, whereas the W-to-Y and W-to-F mutants had little or no effect on the potency of Mg2+ measured at -70 mV (Table 1). Thus, the presence of an amino acid with an aromatic side chain (Y or F) at position NR2B(W607) can restore block by extracellular Mg2+.

Block by Mg2+ is voltage dependent, and we therefore studied I-V relationships of glutamate-induced currents in the absence and presence of Mg2+. At wild-type NR1/NR2B receptors, block by Mg2+ (1-1000 µM) was strongly concentration- and voltage-dependent (Fig. 1D). In contrast, at concentrations below 100 µM, Mg2+ had no effect on the I-V relationship at NR1/NR2B(W607L) receptors (data not shown), and at concentrations of 100-1000 µM Mg2+ produced a very small block at hyperpolarized membrane potentials (Fig. 1E). The NR2B(W607Y) mutation does not affect the potency of Mg2+ measured at -70 mV (Table 1). However, voltage-dependent block by Mg2+ at NR1/NR2B(W607Y) receptors was more shallow than at wild-type receptors. At wild-type receptors, there was a clear region of negative slope conductance with 10-1000 µM Mg2+ and a complete block at extreme negative potentials with 1000 µM Mg2+. In contrast, at NR1/NR2B(W607Y) receptors, the slope conductance with 10-1000 µM Mg2+ was shallow, and there was an incomplete block with 1000 µM Mg2+ (Fig. 1F) The difference between wild-type NR1/NR2B and NR1/NR2B(W607Y) receptors is illustrated in Fig. 1G. These data suggest that Mg2+ is able to permeate NR1/NR2B(W607Y) channels more easily than wild-type channels, manifest as a partial relief from block at very negative potentials, although Mg2+ block at -70 mV is unaffected by W607Y (Table 1). In experiments using Mg2+ as the main extracellular charge carrier, we subsequently found that this is indeed the case (see below). The profile seen with NR2B(W607F) was similar to that of the wild-type channels, with a steep region of negative slope conductance in the presence of extracellular Mg2+ (data not shown).

Some mutations in the M2 region of NR1, including NR1(N616Q), reduce the sensitivity of NMDA receptors to proton inhibition and increase the potencies of glutamate and glycine (Kashiwagi et al., 1997). These effects presumably reflect long range allosteric changes or disruptions to channel gating because NR1(N616) lies in the ion permeation pathway and is not directly involved in binding of protons or agonists. We determined the effects of NR2B(W607) mutations on sensitivity to glutamate, glycine, and pH. These parameters were unaffected by mutations at NR2B(W607) (Table 2).

Permeation of Mg2+ and Ba2+ through NMDA channels. Although the NMDA channel is a relatively nonselective cation channel, the pore must contain a selectivity filter that allows passage of Ca2+ and Ba2+, which are highly permeable, but not of Mg2+, which permeates native NMDA channels very poorly (Mayer and Westbrook, 1987; Stout et al., 1996). To determine whether NR2B(W607) mutations alter Mg2+ permeability and to study the relationship between block and permeation of Mg2+, we measured currents through wild-type and mutant channels with Na+ or Mg2+ as the major extracellular cation. In the absence of Mg2+, and with Na+ as the main extracellular cation (Na+ saline), currents through NR1/NR2B and NR1/NR2B(W607L) receptors had similar reversal potentials, close to 0 mV (Fig. 2, B and C). Under conditions where extracellular Na+ was replaced by Mg2+, outward currents were observed at wild-type NR1/NR2B receptors and these currents asymptotically approached zero as the oocytes were hyperpolarized (Fig. 2B). This suggests that Mg2+ does not permeate these channels or that the reversal potential (Vrev) for Mg2+ is more negative than -100 mV. In contrast, large inward currents were seen in Mg2+ saline at NR1/NR2B(W607L) receptors, and Vrev in Mg2+ saline was -25 ± 1 mV (16 oocytes) (Fig. 2). A similar increase in Mg2+ permeability was seen with a mutation at NR2A(W606L), a position equivalent to NR2B(W607L), and Vrev in Mg2+ saline at NR1/NR2A(W606L) receptors was -28 ± 2 mV (nine oocytes).

We could measure reversal potentials in Mg2+ saline for each of the five NR2B(W607) mutants (Fig. 2C). The W607L, W607N, and W607A mutants all produced large inward currents in Mg2+ saline, whereas currents through receptors with the W607Y and, in particular, W607F mutants were very small (shown for W607Y in Fig. 2B). Differences in the size of macroscopic currents carried by Mg2+ are shown quantitatively in Fig. 2D, in which the ratio of the slope conductance at -50 mV and +50 mV is plotted for each mutant. Thus, although the W607Y and W607F mutants are more permeable to Mg2+ than wild-type channels, the Mg2+ block at these mutants is much more profound than at the W607L, W607N, or W607A mutants. The values of Vrev for Mg2+ observed with the different NR2B(W607) mutants were very similar (Fig. 2C) even though the W-to-Y and W-to-F mutants produced very small currents (Fig. 2D). This suggests that residue NR2B(W607) predominantly affects block by Mg2+ per se rather than affecting the rate of permeation of the ion after the block is relieved. Thus, the strength of the block at wild-type channels that contain a tryptophan at NR2B(W607) presumably accounts for the lack of permeation of Mg2+ through those channels.

To determine whether the NR2B(W607L) mutations alter Ba2+ permeability, we compared Vrev in Na+ saline and in a solution containing 64 mM Ba2+ (Ba2+ saline). Because wild-type NMDA channels are highly permeable to Ba2+, there is a large positive shift in Vrev when switching from Na+ saline to Ba2+ saline (Hume et al., 1991). Even with Ba2+ in the extracellular solution it is possible to activate secondary Cl- conductances that would influence the measured reversal potential. We attempted to eliminate these Cl- currents by injecting oocytes with BAPTA, by limiting the duration of agonist application, and, in some experiments with Ba2+ saline, by reducing the concentration of glutamate from 10 to 1 µM. At wild-type NR1/NR2B receptors, the shift in Vrev was +22 ± 1 mV (Fig. 2E). At receptors containing the NR2B mutants W607L, W607N, and W607A, but not W607Y or W607F, Ba2+ permeability was markedly reduced (Fig. 2E). Thus, residue NR2B(W607) influences Ba2+ permeability as well as Mg2+ block. It may be that transient binding of Ba2+ to NR2B(W607), and subsequent unbinding and passage of Ba2+ through the channel, is involved in Ba2+ flux through wild-type channels. These data are consistent with the reported interactions between Ba2+ (or Ca2+) and Mg2+ within NMDA channels (Mayer and Westbrook, 1987).

Reversal potentials in extracellular Na+, Mg2+, and Ba2+ were measured for receptors containing various combinations of NR1 and NR2 mutants (Figs. 3 and 4). A W-to-L mutation at NR1(W608L) had no effect on Mg2+ permeation and produced a small decrease in Ba2+ permeability (Figs. 3A and 4A). Mutations at the second tryptophan residue in the M2 loop of NR2 subunits, NR2B(W610L) and NR2A(W609L), but not at the equivalent position in NR1, increased permeation of Mg2+ (Fig. 4, A and D), although inward currents carried by Mg2+ through these channels were very small (Fig. 3C) and reversal potentials were more negative than that seen with NR2B(W607L). When the NR2B(W610L) mutant was studied in combination with the NR1(W608L) or NR1(W611L) mutants, there was no further increase in Mg2+ permeability and only a small change in Ba2+ permeability. Similarly, the combination of NR2B(W607L) with NR1(W608L) or NR1(W611L) did not produce any further change in Mg2+ permeability compared with NR1/NR2B(W607L) receptors (Fig. 4A). Thus, of the tryptophan residues present in this region of the pore, only the first tryptophan in NR2 subunits is a major determinant of Mg2+ block. GluR subunits of alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and kainate receptors contain a leucine residue at the position equivalent to NR1(W611) and NR2B(W610). Mutation of this leucine to tryptophan in the GluR1 subunit has been reported to increase divalent cation permeability of homomeric GluR1 channels (Ferrer-Montiel et al., 1996). Our results show that mutations NR1(W611L) and NR2B(W610L), either alone or in combination, have little or no effect on Ba2+ permeability (Fig. 4A), suggesting that the tryptophan at this position in NMDA channels plays only in minor role in controlling Ba2+ permeability.

We also carried out experiments to compare the effects of the NR2B(W607L) mutant with those of mutations at NR1(N616) (Figs. 3B and 4B) and NR2B(N616) (Figs. 3D and 4C), in some cases combining the NR1 and NR2 mutants to determine whether the effect of one mutant predominates. N-to-G, N-to-R, and N-to-W mutations at NR1(N616) all increased Mg2+ permeability and decreased Ba2+ permeability (Fig. 4B), although inward currents carried by Mg2+ through these mutants were very small (Fig. 3B). With the exception of NR1(N616R), the NR2B(W607L) mutant seemed to predominantly influence Mg2+ permeability (Fig. 4B). In contrast, the NR1(N616) mutants predominantly influenced Ba2+ permeability in NR1(N616X)/NR2B(W607L) channels (Fig. 4B).

The NR2B(N616G) mutant greatly increased Mg2+ permeability and reduced Ba2+ permeability, similar to the NR2B(W607L) mutant (Figs. 3D and 4C). A double mutant, NR2B(W607L,N616G), did not have a greater effect than either mutant alone, nor did the combination of NR2B(N616G) with NR1(N616G) (Fig. 4C). Similar results were seen with an N615G mutant in NR2A, which increased Mg2+ permeability comparable with the NR2A(W606L) mutant (Fig. 4D). The lack of additivity of the mutations at NR2B(W607) and NR2B(N616) suggests that these residues may make a similar or functionally overlapping contribution to the Mg2+ binding site and they may be closely positioned in the pore (Fig. 5).

Implications for understanding Mg2+ block and the structure of NMDA channels. A tryptophan residue is present in all glutamate receptor subunits, with the exception of NR-L, and in some K+ channel subunits at a position equivalent to NR2B(W607). In NMDA channels (Kuner et al., 1996) and in Shaker K+ channels (Lü and Miller, 1995), the tryptophan at this position has been reported to face the lumen of the channel pore. This would be consistent with a direct interaction of Mg2+ with NR2B(W607) in the NMDA channel lumen, possibly involving a cation-pi interaction of Mg2+ with the aromatic ring of W607 (Kumpf and Dougherty, 1993). In support of this idea, block by Mg2+ was drastically reduced in mutants containing leucine, asparagine, or alanine but was largely unaffected in mutants containing tyrosine or phenylalanine. Based on the kinetics of block by external and internal Mg2+, a barrier-well energy profile has been proposed for Mg2+ block of the NMDA channel (Li-Smerin and Johnson, 1996). That profile contains a very high energy barrier that prevents crossover and permeation of internal Mg2+ (Li-Smerin and Johnson, 1996). It is tempting to speculate that the tryptophan residue at position NR2B(W607) is the actual physical determinant of that energy barrier, and it will be of interest to study the influence of NR2B(W607) on block by intracellular Mg2+.

It is clear that the presence of a tryptophan by itself is not sufficient to confer channel block by extracellular Mg2+ because other subtypes of glutamate receptors are not blocked by external Mg2+ and, as shown here, W608 in the NR1 subunit does not influence Mg2+ block. Additional features of the NMDA channel must also control binding and permeation of Mg2+, possibly including an interaction of Mg2+ with the carbonyl oxygens of the M2 asparagine residues (Burnashev et al., 1992; Kawajiri and Dingledine, 1993; Kupper et al., 1996). Another possibility is that the structure, folding, or positioning of the M2 loop in NR2 subunits is different from that in subunits of non-NMDA receptors and, perhaps, different from that in NR1, and that this accounts for the role of NR2B(W607) in Mg2+ block

We previously found that the NR2B(W607L) but not the NR1(W608L) mutation reduced block and increased the apparent permeation of the polyamine-derivative N1-DnsSpm (Kashiwagi et al., 1997). Those results led us to propose that residue NR2B(W607) may contribute to the narrowest constriction of the channel pore (Kashiwagi et al., 1997) together with the asparagines at positions NR1(N616) and NR2B(N616) (Kuner et al., 1996; Wollmuth et al., 1996), although this is not consistent with current models of the proposed structure of the M2 loop region in which NR2B(W607) lies some distance below NR2B(N616) (Kuner et al., 1996; Sutcliffe et al., 1996). The finding that W607 in NR2B but not W608 in NR1 affects Mg2+ block reinforces the idea that the M2 regions of NR1 and NR2 make nonsymmetrical contributions to channel structure. It may be that the secondary structure of at least part of the M2 loop in NR1 and NR2 subunits is different, leading to placement of NR2B(W607) at a position in the channel pore such that it can interact with Mg2+ whereas NR1(W608) cannot (Fig. 5). If residue NR2B(W607) is located at a level in the channel similar to NR1(N616) and NR2B(N616) (Fig. 5A), it is possible that some or all of the M2 region extends in a plane parallel, rather than perpendicular, to the plane of the membrane, as has been proposed for the pore-forming loop of a cyclic nucleotide-gated channel (Sun et al., 1996). A limitation of models such as those shown in Fig. 5 is that they are "static," and it is possible that the M2 loops are very flexible, as has been proposed for pore-forming loops of voltage-gated Na+ and K+ channels (Bénitah et al., 1997; Liu et al., 1996; Tsushima et al., 1997) and that under some conditions they can arrange themselves such that NR2B(W607) is very close to or forms part of the narrow constriction and the selectivity filter in the channel.

We found that a W-to-L mutation at the second tryptophan in NR2B, NR2B(W610), also had a small effect on Mg2+ block. In the study by Kuner et al. (1996), the equivalent tryptophan residues in NR1 and NR2C were not accessible to thiol reagents after mutagenesis to cysteine, suggesting that this tryptophan is not solvent accessible in the channel. If NR2B(W610) does not face the channel lumen, it is possible that the W-to-L mutation causes a nonspecific disruption of channel structure, perhaps influencing the position of the NR2B(W607) or NR2B(N616) residues. In this context, it is notable that mutations at NR1(S617) have a small effect on Mg2+ block (Kawajiri and Dingledine, 1993), although this position is also not accessible to thiol reagents after cysteine mutagenesis (Kuner et al., 1996). Another possibility is that residues such as NR2B(W610) and NR1(S617) do face the channel lumen but their accessibility is limited because of shielding by other residues or by ions passing through the channel.

In conclusion, we propose that there are at least three residues that make critical contributions to the narrow constriction and selectivity filter of the NMDA channel. These include N616 in NR1 and N616 and W607 in NR2B (Fig. 5). The N and W residues in NR2 subunits predominantly influence block and permeation of extracellular Mg2+ and probably form part of a Mg2+ binding site. Although the schematics shown in Fig. 5 are undoubtedly a gross oversimplification, future models of the M2 region will need to take into account a critical role for the conserved tryptophan in NR2 subunits in block by Mg2+, as well as the potential positioning of this residue at the narrow constriction of the channel (Kashiwagi et al., 1997).

    Footnotes

Received October 14, 1997; Accepted January 29, 1998

This work was supported by United States Public Health Service Grant NS35047 from the National Institute of Neurological Disorders and Stroke, a Grant-in-Aid from the American Heart Association, and grants from the Japan Health Science Foundation and the Yamanouchi Foundation for Research on Metabolic Disorders.

Send reprint requests to: Dr. Keith Williams, Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6084. E-mail: williams{at}pharma.med.upenn.edu

    Abbreviations

NMDA, N-methyl-D-aspartate; N1-DnsSpm, N1-dansyl-spermine; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; GluR, glutamate receptor; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; I-V, current-voltage.

    References
Top
Summary
Introduction
Materials & Methods
Results & Discussion
References


0026-895X/98/050933-09$3.00/0
MOLECULAR PHARMACOLOGY, 53:933-941 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. Masuko, R. Namiki, Y. Nemoto, M. Miyake, Y. Kizawa, T. Suzuki, K. Kashiwagi, K. Igarashi, and T. Kusama
Neuroprotection by Tosyl-Polyamine Derivatives through the Inhibition of Ionotropic Glutamate Receptors
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 522 - 530.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Jin, M. Miyazaki, S. Mizuno, M. Takigawa, T. Hirose, K. Nishimura, T. Toida, K. Williams, K. Kashiwagi, and K. Igarashi
The Pore Region of N-Methyl-D-aspartate Receptors Differentially Influences Stimulation and Block by Spermine
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 68 - 77.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
T. J. Wilding, E. Fulling, Y. Zhou, and J. E. Huettner
Amino Acid Substitutions in the Pore Helix of GluR6 Control Inhibition by Membrane Fatty Acids
J. Gen. Physiol., July 1, 2008; 132(1): 85 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Jin, H. Sugiyama, M. Takigawa, D. Katagiri, H. Tomitori, K. Nishimura, N. Kaur, O. Phanstiel IV, M. Kitajima, H. Takayama, et al.
Comparative Studies of Anthraquinone- and Anthracene-Tetraamines as Blockers of N-Methyl-D-aspartate Receptors
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 47 - 55.
[Abstract] [Full Text] [PDF]


Home page
Biol. Bull.Home page
T. J. Ha, A. B. Kohn, Y. V. Bobkova, and L. L. Moroz
Molecular Characterization of NMDA-Like Receptors in Aplysia and Lymnaea: Relevance to Memory Mechanisms
Biol. Bull., June 1, 2006; 210(3): 255 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Qian, A. L. Buller, and J. W. Johnson
NR2 subunit-dependence of NMDA receptor channel block by external Mg2+
J. Physiol., January 15, 2005; 562(2): 319 - 331.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi
Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Kashiwagi, T. Masuko, C. D. Nguyen, T. Kuno, I. Tanaka, K. Igarashi, and K. Williams
Channel Blockers Acting at N-Methyl-D-aspartate Receptors: Differential Effects of Mutations in the Vestibule and Ion Channel Pore
Mol. Pharmacol., March 1, 2002; 61(3): 533 - 545.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Vissel, J. J. Krupp, S. F. Heinemann, and G. L. Westbrook
Intracellular Domains of NR2 Alter Calcium-Dependent Inactivation of N-Methyl-D-aspartate Receptors
Mol. Pharmacol., March 1, 2002; 61(3): 595 - 605.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
V. A. Panchenko, C. R. Glasser, and M. L. Mayer
Structural Similarities between Glutamate Receptor Channels and K+ Channels Examined by Scanning Mutagenesis
J. Gen. Physiol., April 1, 2001; 117(4): 345 - 360.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-K. Tai, S. E. Blondelle, J. M. Ostresh, R. A. Houghten, and M. Montal
An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity
PNAS, March 13, 2001; 98(6): 3519 - 3524.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
W. R. Silverman, C.-Y. Tang, A. F. Mock, K.-B. Huh, and D. M. Papazian
Mg2+ Modulates Voltage-Dependent Activation in Ether-a-Go-Go Potassium Channels by Binding between Transmembrane Segments S2 and S3
J. Gen. Physiol., November 1, 2000; 116(5): 663 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. I Sobolevsky and M. V Yelshansky
The trapping block of NMDA receptor channels in acutely isolated rat hippocampal neurones
J. Physiol., August 1, 2000; 526(3): 493 - 506.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sheng, J. Li, K. A. McNulty, D. Avery, and T. R. Kleyman
Characterization of the Selectivity Filter of the Epithelial Sodium Channel
J. Biol. Chem., March 17, 2000; 275(12): 8572 - 8581.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-K. Sun, T. J. Nelson, H. Xu, and D. L. Alkon
Calexcitin transformation of GABAergic synapses: From excitation filter to amplifier
PNAS, June 8, 1999; 96(12): 7023 - 7028.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams
A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, K.
Right arrow Articles by Igarashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, K.
Right arrow Articles by Igarashi, K.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics